Phillip De Noble, PharmD

Phillip De Noble, PharmD has a range of experience in the pharmaceutical and healthcare industry. Phillip currently holds the position of VP of Regulatory Affairs at Lantheus since April 2023. Prior to that, they were a Regulatory Advisor & Co-founder at Evergreen Theragnostics starting from June 2019. Phillip also worked at Curie Therapeutics as the VP of Regulatory and Quality from August 2022 to April 2023 and as a Sr. Director - Regulatory Affairs & Quality Assurance (Head of Quality) from August 2021 to August 2022. Additionally, they worked as a Consultant at Curie Therapeutics from June 2021 to August 2021.

Phillip's previous work experience includes roles at Sanofi Genzyme as the Associate Director CMC Regulatory Affairs from January 2020 to April 2022, Progenics Pharmaceuticals, Inc. as the Associate Director of Regulatory Affairs - CMC from May 2019 to January 2020, and as a Consultant from December 2018 to May 2019. Phillip also served as the Sr. Manager, Regulatory Affairs at Baxter International Inc. from April 2018 to May 2019.

Earlier in their career, Phillip held positions at NYU Langone Medical Center as the Operational Director - Research Scientist; cGMP from April 2017 to March 2018, Memorial Sloan Kettering Cancer Center as a QA/QP Radiopharmacist - cGMP Manufacturing from August 2014 to April 2017, Massachusetts General Hospital as a PET Radiochemistry Intern from September 2011 to July 2014, and Siemens Healthcare as a PET Radiochemistry Intern for a brief period in July 2013.

Overall, Phillip De Noble, PharmD has a strong background in regulatory affairs, quality assurance, and pharmaceutical manufacturing.

Phillip De Noble, PharmD, received their education in a chronological order. Phillip completed their Bachelor's degree in Health Sciences with a focus on Biological Sciences from the University of Central Florida from 2006 to 2009. Subsequently, they pursued their Doctor of Pharmacy (PharmD) degree from the Massachusetts College of Pharmacy and Health Sciences from 2010 to 2014.

In addition to their educational background, Phillip De Noble has obtained certain certifications. Phillip is a Registered Pharmacist, certified by the New York State Department of Health, which they obtained in August 2014. Phillip also holds the designation of an Authorized User, acquired from the NRC. Furthermore, they possess Dual US/Canadian Citizenship, although the institution or date of obtaining this status is not provided.